Mitochondrial Dysfunction and Nanotherapeutics: Aging, Diseases and Nanotechnology-Related Strategies in Mitochondrial Medicine provide a comprehensive overview of the Mitochondrial disfunction, and current strategies for targeting the organelle. Based on the most current research, the Editor lined up a team of worldwide experts to cover the most exciting research in the area, considering the impact through the human life span.

The book is structured in two parts that provide a good balance of foundational and applied content around the theme. Part I deals with an overview of mitochondrial dysfunction and its role in the aging process, including metabolic diseases, neuro affective and neurodegenerative disorders, sepsis, and toxicology. Part II covers therapeutic substance delivery to the organelle, focused on cancer, neurodegenerative diseases and increasing the bioavailability of natural compounds of interest. Several nano-scale strategies are described.

Mitochondrial Dysfunction and Nanotherapeutics: Aging and Diseases and Nanotechnology-Related Strategies in Mitochondrial Medicine is a complete resource for researchers in this exciting field. Its comprehensive coverage makes it particularly interesting to bioscience researchers willing to understand the foundations of mitochondrial health through the human lifespan. Clinician Researchers, MDs, nutritionists, pharmacologists, and sports scientists may be attracted to the detailed information on the organelle targeted delivery strategies.